Evidence map›Paper›PMID 28985418›Full record

ArticleNucleic acids research2018

The SysteMHC Atlas project.

Wenguang Shao, Patrick G A Pedrioli, Witold Wolski, Cristian Scurtescu, Emanuel Schmid, Juan A Vizcaíno, Mathieu Courcelles, Heiko Schuster, Daniel Kowalewski, Fabio Marino and 36 more

Abstract readDataset
In one paragraph

Article in Nucleic acids research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 89 papers.

0numbers the graph read from it
0cells of the map it votes in
89citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

89 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Data-Independent Acquisition Peptidomics.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  14. Review
  15. Review
  16. TOFNature communications · 2023
    Article
  17. Article
  18. Review
  19. Review
  20. Review

29 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

46 authors.

Wenguang ShaoDepartment of Biology, Institute of Molecular Systems Biology, ETH Zurich, Zurich 8093, Switzerland.
Patrick G A PedrioliDepartment of Biology, Institute of Molecular Systems Biology, ETH Zurich, Zurich 8093, Switzerland.
Witold WolskiFunctional Genomics Center Zurich, ETH Zurich and University of Zurich, Zurich 8057, Switzerland.
Cristian ScurtescuScientific IT Services (SIS), ETH Zurich, Zurich 8093, Switzerland.
Emanuel SchmidScientific IT Services (SIS), ETH Zurich, Zurich 8093, Switzerland.
Juan A VizcaínoEuropean Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Trust Genome Campus, Hinxton, Cambridge, CB10 1SD, UK.
Mathieu CourcellesInstitute for Research in Immunology and Cancer, Université de Montréal, Montreal, H3T 1J4, Canada.
Heiko SchusterDepartment of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, 72076, Germany.
Daniel KowalewskiDepartment of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, 72076, Germany.
Fabio MarinoLudwig Institute for Cancer Research, University Hospital of Lausanne, Lausanne 1011, Switzerland.
Cecilia S L ArlehamnLa Jolla Institute for Allergy and Immunology, La Jolla, CA 92037, USA.
Kerrie VaughanLa Jolla Institute for Allergy and Immunology, La Jolla, CA 92037, USA.
Bjoern PetersLa Jolla Institute for Allergy and Immunology, La Jolla, CA 92037, USA.
Alessandro SetteLa Jolla Institute for Allergy and Immunology, La Jolla, CA 92037, USA.
Tom H M OttenhoffDepartment of Infectious Diseases, Leiden University Medical Center, Leiden, 2333 ZA, The Netherlands.
Krista E MeijgaardenDepartment of Infectious Diseases, Leiden University Medical Center, Leiden, 2333 ZA, The Netherlands.
Natalie NieuwenhuizenDepartment of Immunology, Max Planck Institute for Infection Biology, Berlin 10117, Germany.
Stefan H E KaufmannDepartment of Immunology, Max Planck Institute for Infection Biology, Berlin 10117, Germany.
Ralph SchlapbachFunctional Genomics Center Zurich, ETH Zurich and University of Zurich, Zurich 8057, Switzerland.
John C CastleVaccine Research and Translational Medicine, Agenus Switzerland Inc., 4157 Basel, Switzerland.
Alexey I NesvizhskiiDepartment of Pathology, BRCF Metabolomics Core, University of Michigan, Ann Arbor, MI 48109, USA.
Morten NielsenInstituto de Investigaciones Biotecnológicas, Universidad Nacional de San Martín, Buenos Aires, 1650, Argentina.
Eric W DeutschInstitute for Systems Biology, Seattle, WA 98109, USA.
David S CampbellInstitute for Systems Biology, Seattle, WA 98109, USA.
Robert L MoritzInstitute for Systems Biology, Seattle, WA 98109, USA.
Roman A ZubarevDivision of Physiological Chemistry I, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, SE-171 77, Sweden.
Anders Jimmy YtterbergDivision of Physiological Chemistry I, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, SE-171 77, Sweden.
Anthony W PurcellInfection and Immunity Program, Department of Biochemistry and Molecular Biology, Monash Biomedicine Discovery Institute, Monash University, Clayton 3800, Australia.
Miguel MarcillaProteomics Unit, Spanish National Biotechnology Centre, Madrid 28049, Spain.
Alberto ParadelaProteomics Unit, Spanish National Biotechnology Centre, Madrid 28049, Spain.
Qi WangCenter for Biomedical Mass Spectrometry, Department of Biochemistry, Boston University School of Medicine, Boston, MA 02118, USA.
Catherine E CostelloCenter for Biomedical Mass Spectrometry, Department of Biochemistry, Boston University School of Medicine, Boston, MA 02118, USA.
Nicola TernetteThe Jenner Institute, Target Discovery Institute Mass Spectrometry Laboratory, University of Oxford, Oxford, OX3 7FZ, UK.
Peter A van VeelenCenter for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, 2333 ZA, The Netherlands.
Cécile A C M van ElsCentre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, 3720 BA, The Netherlands.
Albert J R HeckBiomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Utrecht University, 3584 CH, The Netherlands.
Gustavo A de SouzaCentre for Immune Regulation, Department of Immunology, University of Oslo and Oslo University Hospital-Rikshospitalet, Oslo 0372, Norway.
Ludvig M SollidCentre for Immune Regulation, Department of Immunology, University of Oslo and Oslo University Hospital-Rikshospitalet, Oslo 0372, Norway.
Arie AdmonDepartment of Biology, Technion, Israel Institute of Technology, Haifa 3200003, Israel.
Stefan StevanovicDepartment of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, 72076, Germany.
Hans-Georg RammenseeDepartment of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, 72076, Germany.
Pierre ThibaultInstitute for Research in Immunology and Cancer, Université de Montréal, Montreal, H3T 1J4, Canada.
Claude PerreaultInstitute for Research in Immunology and Cancer, Université de Montréal, Montreal, H3T 1J4, Canada.
Michal Bassani-SternbergLudwig Institute for Cancer Research, University Hospital of Lausanne, Lausanne 1011, Switzerland.
Ruedi AebersoldDepartment of Biology, Institute of Molecular Systems Biology, ETH Zurich, Zurich 8093, Switzerland.
Etienne CaronDepartment of Biology, Institute of Molecular Systems Biology, ETH Zurich, Zurich 8093, Switzerland.

Funding

Quantitative Systems BiologyP50GM076547 · NIGMS · INSTITUTE FOR SYSTEMS BIOLOGY · PI DUDLEY, AIMEE M · 2006 to 2016
$30.6M
Shortening the development cycle time of Trans Proteomic Pipeline tools with high performance computingR01GM087221 · NIGMS · INSTITUTE FOR SYSTEMS BIOLOGY · PI DEUTSCH, ERIC, MORITZ, ROBERT L · 2010 to 2021
$6.0M
COMPUTATIONAL TOOLS FOR MASS SPECTROMETRY-BASED INTERACTOME DATAR01GM094231 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Alexey I Nesvizhskii · 2010 to 2026
$5.4M
University of Michigan Proteogenomics Data Analysis CenterU24CA210967 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CHINNAIYAN, ARUL M, DHANASEKARAN, SARAVANA M · 2016 to 2020
$4.1M
European Research Council 670821NCI NIH HHS U24 CA210967NIGMS NIH HHS P50 GM076547NIGMS NIH HHS R01 GM087221NIGMS NIH HHS R01 GM094231
6 · The paper itself

Abstract

Mass spectrometry (MS)-based immunopeptidomics investigates the repertoire of peptides presented at the cell surface by major histocompatibility complex (MHC) molecules. The broad clinical relevance of MHC-associated peptides, e.g. in precision medicine, provides a strong rationale for the large-scale generation of immunopeptidomic datasets and recent developments in MS-based peptide analysis technologies now support the generation of the required data. Importantly, the availability of diverse immunopeptidomic datasets has resulted in an increasing need to standardize, store and exchange this type of data to enable better collaborations among researchers, to advance the field more efficiently and to establish quality measures required for the meaningful comparison of datasets. Here we present the SysteMHC Atlas (https://systemhcatlas.org), a public database that aims at collecting, organizing, sharing, visualizing and exploring immunopeptidomic data generated by MS. The Atlas includes raw mass spectrometer output files collected from several laboratories around the globe, a catalog of context-specific datasets of MHC class I and class II peptides, standardized MHC allele-specific peptide spectral libraries consisting of consensus spectra calculated from repeat measurements of the same peptide sequence, and links to other proteomics and immunology databases. The SysteMHC Atlas project was created and will be further expanded using a uniform and open computational pipeline that controls the quality of peptide identifications and peptide annotations. Thus, the SysteMHC Atlas disseminates quality controlled immunopeptidomic information to the public domain and serves as a community resource toward the generation of a high-quality comprehensive map of the human immunopeptidome and the support of consistent measurement of immunopeptidomic sample cohorts.

Indexed as

Databases, FactualHistocompatibility AntigensHLA AntigensMass SpectrometryAllelesHumansInternetTandem Mass SpectrometryUser-Computer InterfaceHistocompatibility AntigensHLA Antigens

Identifiers

PMID28985418
PMCPMC5753376

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.